Search
Related topics are listed below.
Step 3: CTA Discrepancy Process
Continuous Process Improvement Program (CPI) » Consecutive Transplant Audit (CTA) » Step 3: CTA Discrepancy Process
In order to remain in Good Standing for CPI, centers must address all discrepancies between the provided CTA list and the data reported to FormNet3 by the end of Trimester 2 (August 31st for US centers, October 31st for International centers). This requirement is not…
Downloading CTA Files
Continuous Process Improvement Program (CPI) » Consecutive Transplant Audit (CTA) » Downloading CTA Files
Steps to Access and Download the CTA File 1. Log into CIBMTR Portal (https://portal.cibmtr.org) Submit a request to CIBMTR Center Support if you have any trouble accessing the CIBMTR Portal or if you have a user account and need additional access. Choose category…
Consecutive Transplant Audit (CTA)
Continuous Process Improvement Program (CPI) » Consecutive Transplant Audit (CTA)
Each year CIBMTR performs a consecutive transplant audit (CTA) for all active centers to ensure the epidemiological integrity of the CIBMTR outcomes registry and to provide the US government with an accurate assessment of transplant activity. The audit ensures all…
Forms Completion List
Corporate Studies and Registries » Forms Completion List
CIBMTR Corporate Studies and Registries Forms Completion List The Corporate Studies and Registries Forms Completion List is automatically sent the first Tuesday of the month via email. If you have questions about forms in these reports, contact CIBMTR Center…
Form Completion Standards
Continuous Process Improvement Program (CPI) » Form Completion Standards
CIBMTR has revised the CPI Form Completion Standards to better align the requirements with the data needs of the transplant community, as well as to simplify the metrics tracked to improve the quality and availability of research data. These updates will streamline the…
Step 2: International Centers – Submit CTA List to CIBMTR
Continuous Process Improvement Program (CPI) » Consecutive Transplant Audit (CTA) » Step 2: International Centers – Submit CTA List to CIBMTR
In order to remain in Good Standing for CPI, centers must submit a list of all reportable infusions performed at their center in the previous calendar year by the end of Trimester 1 (June 30th). This requirement is not eligible for exemption. Process for Submitting…
Step 2: US Centers – Submit CTA List to CIBMTR
Continuous Process Improvement Program (CPI) » Consecutive Transplant Audit (CTA) » Step 2: US Centers – Submit CTA List to CIBMTR
In order to remain in Good Standing for CPI, centers must submit a list of all reportable infusions performed at their center in the previous calendar year by the end of Trimester 1 (April 30th). This requirement is not eligible for exemption. Process for Submitting…
Part 1: Resolve Discrepancies Between CTA List and FormsNet3/NMDP Operations Data
Continuous Process Improvement Program (CPI) » Consecutive Transplant Audit (CTA) » Step 3: CTA Discrepancy Process » Part 1: Resolve Discrepancies Between CTA List and FormsNet3/NMDP Operations Data
Discrepancy Process During trimester 2, CIBMTR will generate and post a refreshed CTA discrepancy file (see preview below) on the CIBMTR Portal for centers to download every Friday How to download CTA files Centers need to review and resolve the discrepancies…
FormsNet2 Paper EC Process
Data Collection and Quality » Correcting Historical Data » FormsNet2 Paper EC Process
Error corrections for FormsNet2 versions of the forms are available on the Retired Forms page of CIBMTR’s website. Please make sure to use the correct version of the form that was completed for all FormsNet2 documents. The question number and sometimes entire…
Continuous Process Improvement Program (CPI)
Continuous Process Improvement Program (CPI)
Introduction CIBMTR has established processes to assess and close any gaps that exist in data reported to the C.W. Bill Young Cell Transplantation Program (CWBYCTP). The assessment covers unrelated donor transplants facilitated by the CWBYCTP, both within the US and…
FormsNet3 Process and Tool Instructions
FormsNet3 Process and Tool Instructions
The FormsNet3 Process and Tool Instructions section contains information on the successful completion of the various FormsNet3 tools. Contents of this section: 2804: CIBMTR Research ID Assignment FormsNet3 Consent Tool 2814: Indication for CRID Assignment Recipient…
Inherited disorders of metabolism
Data Collection and Quality » Primary Disease and Disease Forms Due » Inherited disorders of metabolism
Disease Subtype(s) HCT Disease Inserts Cellular Therapy Disease Inserts Osteopetrosis(malignant infantile osteopetrosis) (521) Forms 2036 & 2136 No disease insert required Leukodystrophies Metachromatic leukodystrophy…
Inherited abnormalities of platelets
Data Collection and Quality » Primary Disease and Disease Forms Due » Inherited abnormalities of platelets
Disease Subtype(s) HCT Disease Inserts Cellular Therapy Disease Inserts Congenital amegakaryocytosis / congenital thrombocytopenia (501) Forms 2035 & 2135 No disease insert is required Glanzmann thrombasthenia (502) Other…
Age of Majority FAQ
Protocols and Consents » Consent: Age of Majority » Age of Majority FAQ
When is reconsent required? Age of majority reconsent will be continuously required for all participants enrolled to the CIBMTR Research Outcomes Database Protocol under minor consent. Centers under the oversight of the NMDP IRB are required to follow the NMDP IRB’s…
Consent: Age of Majority
Protocols and Consents » Consent: Age of Majority
Age of Majority reconsent is a critical component of the informed consent process. CIBMTR is committed to ensuring that our participants’ right to consent is provided to them once they have reached their age of majority. The following subsections are available for…
Disorders of the immune system
Data Collection and Quality » Primary Disease and Disease Forms Due » Disorders of the immune system
Disease Subtype(s) HCT Disease Inserts Cellular Therapy Disease Inserts Adenosine deaminase (ADA) deficiency / severe combined immunodefiency (SCID)(401) Absence of T and B cells SCID (402) Absence of T, normal B cell SCID (403) Omenn…
Discrepancy: DOB (Date of Birth) Mismatch
Continuous Process Improvement Program (CPI) » Consecutive Transplant Audit (CTA) » Step 3: CTA Discrepancy Process » Part 1: Resolve Discrepancies Between CTA List and FormsNet3/NMDP Operations Data » Discrepancy: DOB (Date of Birth) Mismatch
The patient’s date of birth is discrepant between FormsNet3 and the CTA list. Steps to Follow to Correct Discrepancy If the CTA list is incorrect, centers should correct the CTA list and resubmit via a CIBMTR Center Support ticket. After navigating to…
Entering a New Consent for Age of Majority
Protocols and Consents » Consent: Age of Majority » Entering a New Consent for Age of Majority
Age of Majority Consent for the Research Database *Age of Majority Consent definition – each U.S. state has its own age of majority which is the legally defined age at which a person is considered an adult, with all the attendant rights and responsibilities of…
Acute Leukemias of Ambiguous Lineage and Other Myeloid Neoplasms
Data Collection and Quality » Primary Disease and Disease Forms Due » Acute Leukemias of Ambiguous Lineage and Other Myeloid Neoplasms
Disease Subtype(s) HCT Disease Inserts required Cellular Therapy Disease Inserts required Blastic plasmacytoid dendritic cell neoplasm (296) Acute undifferentiated leukemia (31) Mixed phenotype acute leukemia (MPAL) with…
Determining Total # of CPI Forms Completed in a Week
Continuous Process Improvement Program (CPI) » CPI Resources » CPI Center Forms Due Tool » Determining Total # of CPI Forms Completed in a Week
Step 1: Status codes – Click on “AUD, CMP, LCK, QRY, and PND” (These are the form statuses that are considered “complete for CPI”) Step 2: Forms – Click on the Step 3: The Date Type will auto-populate to equal Form Due Date.…
Determining Total # of CPI Forms Due in a Trimester
Continuous Process Improvement Program (CPI) » CPI Resources » CPI Center Forms Due Tool » Determining Total # of CPI Forms Due in a Trimester
Determine the number of “Critical Forms On-time” that are DUE and COMPLETED Critical Forms On-Time (Due) Critical Forms On-Time (Completed) Step 1: Status Codes – Click on the Step 1: Status codes – Click on…
CIBMTR CPI Summary Report
Continuous Process Improvement Program (CPI) » CPI Resources » CIBMTR CPI Summary Report
The Recipient CPI Summary Report is automatically sent to the current Primary Data Manager(s). Additional center managers can request to be added to the CIBMTR CPI Summary distribution list by contacting CIBMTR via a CIBMTR Center Support ticket. After navigating…
CPI Exemption Request
Continuous Process Improvement Program (CPI) » CPI Resources » CPI Exemption Request
CIBMTR acknowledges a site may have difficulty achieving CPI requirements in a given trimester due to extenuating circumstances, such as staff shortages/turnover, or other unforeseen challenges. To assist sites in meeting CPI requirements in these difficult situations,…
Part 2: Resolve Discrepancies within FormsNet3 Forms (Query Resolution)
Continuous Process Improvement Program (CPI) » Consecutive Transplant Audit (CTA) » Step 3: CTA Discrepancy Process » Part 2: Resolve Discrepancies within FormsNet3 Forms (Query Resolution)
Discrepancy Process (Queries) Once the CTA discrepancies have been resolved, CIBMTR will place queries on FormsNet3 forms containing discrepancies. A list of these queries will be uploaded to the CIBMTR Portal. How to download CTA files Centers will need to…
Welcome
Welcome
CIBMTR Data Management Guide The Data Management Guide contains information on center participation and data submission to CIBMTR and serves as a resource for individuals seeking guidance about forms due, data quality, and the functions of CIBMTR research data…
Discrepancy: Missing CRID
Continuous Process Improvement Program (CPI) » Consecutive Transplant Audit (CTA) » Step 3: CTA Discrepancy Process » Part 1: Resolve Discrepancies Between CTA List and FormsNet3/NMDP Operations Data » Discrepancy: Missing CRID
FormsNet3 does not have a record of the CRID on the CTA list. Steps to Follow to Correct Discrepancy Confirm correct CRID is reported on the CTA list. If the CTA list has an error, make corrections to the CTA list and resubmit via a CIBMTR Center Support…
International Information
Transplant Center Specific Analysis (TCSA) » International Information
Beginning in 2025, the program will open to international centers. Participation in this project is voluntary for international centers. Complete information for variables used in the multivariate analysis is essential to produce a valid report. If a center has…
Discrepancy: HCT Date Mismatch
Continuous Process Improvement Program (CPI) » Consecutive Transplant Audit (CTA) » Step 3: CTA Discrepancy Process » Part 1: Resolve Discrepancies Between CTA List and FormsNet3/NMDP Operations Data » Discrepancy: HCT Date Mismatch
The HCT event date is discrepant between FormsNet3 and the CTA list. Steps to Follow to Correct Discrepancy If the CTA list is incorrect, centers should correct the CTA list and resubmit via a CIBMTR Center Support ticket. After navigating to the CIBMTR Center…
Discrepancy: HCT Type Mismatch
Continuous Process Improvement Program (CPI) » Consecutive Transplant Audit (CTA) » Step 3: CTA Discrepancy Process » Part 1: Resolve Discrepancies Between CTA List and FormsNet3/NMDP Operations Data » Discrepancy: HCT Type Mismatch
The HCT type is discrepant between FormsNet3 and the CTA list. Steps to Follow to Correct Discrepancy If the CTA list is incorrect, centers should correct the CTA list and resubmit via a CIBMTR Center Support ticket. After navigating to the CIBMTR Center…
Discrepancy: Sex Mismatch
Continuous Process Improvement Program (CPI) » Consecutive Transplant Audit (CTA) » Step 3: CTA Discrepancy Process » Part 1: Resolve Discrepancies Between CTA List and FormsNet3/NMDP Operations Data » Discrepancy: Sex Mismatch
The patient’s sex is discrepant between FormNet3 and the CRA list. Steps to Follow to Correct Discrepancy If the CTA list is incorrect, centers should correct the CTA list and resubmit via a CIBMTR Center Support ticket. After navigating to the CIBMTR…
Step 1: Report Infusions in FormsNet3
Continuous Process Improvement Program (CPI) » Consecutive Transplant Audit (CTA) » Step 1: Report Infusions in FormsNet3
Centers must register new patients in FormsNet3 within 30 days of their first infusion. Reporting Requirements US Centers The US Government requires all US Centers to report allogeneic related and unrelated donor HCTs performed at their center, regardless of…
Discrepancy: HCT Date Missing
Continuous Process Improvement Program (CPI) » Consecutive Transplant Audit (CTA) » Step 3: CTA Discrepancy Process » Part 1: Resolve Discrepancies Between CTA List and FormsNet3/NMDP Operations Data » Discrepancy: HCT Date Missing
FormsNet3 does not have a record of the HCT reported on the CTA list. For these cases, a CRID exists, and the infusion will need to be reported in FormsNet3. Steps to Follow to Correct Discrepancy For a patient’s first infusion, complete the…
Determining CPI Metrics from Center Forms Due Tool
Continuous Process Improvement Program (CPI) » CPI Resources » CPI Center Forms Due Tool » Determining CPI Metrics from Center Forms Due Tool
*Equation: (total forms) x (% form requirement) = (forms to complete to meet requirement) – (forms completed) = (additional forms to complete to meet requirement) Step 1: Once the number of center forms due (in the desired category) has been determined using…
Recipient Transfer Best Practices
FormsNet3 Process and Tool Instructions » Recipient Transfer Tool » Recipient Transfer Best Practices
I have received a transfer request; how quickly do I need to respond? Please respond to a transfer request within two weeks. Requests will appear on the FormsNet3 homepage and via email notification. It is very important to not delay a transfer so that centers have…
International Centers
Protocols and Consents » International Centers
International Centers – Institutional Review Board (IRB) Approval International transplant centers must follow their country’s laws and regulations governing human subjects and privacy protection. The transplant center is responsible for obtaining the…
Corporate Studies and Registries
Corporate Studies and Registries
There are two lists related to CIBMTR Corporate Studies and Registries that are sent via email Forms Due List Forms Completion List These are automatically sent to current Primary Data Managers and staff we’ve been asked to copy on correspondence sent to the…
2814: Indication for CRID Assignment
FormsNet3 Process and Tool Instructions » 2814: Indication for CRID Assignment
The Indication for CRID Assignment (Form 2814) collects information to initiate CIBMTR reporting on appropriate research or data collection forms. This form must be completed for the first indication requiring the individual to register for a CIBMTR Research ID (CRID).…
Center Compliance
Continuous Process Improvement Program (CPI) » Center Compliance
Compliance Monitoring Centers should monitor their compliance to the CPI requirements throughout the trimester. The form completion categories are important to monitor as the total number of forms needed to meet the targets will fluctuate throughout the trimester.…
FormsNet3 Consent Tool
FormsNet3 Process and Tool Instructions » FormsNet3 Consent Tool
Recipient consent for the CIBMTR research database (ClinicalTrials.gov Identifier: NCT01166009) is collected in the Consent Tool within FormsNet3. The Consent Tool allows recipient consent status and contact information to be collected as soon as possible after the…
CIBMTR Guidance Document for Reporting Autologous Cellular Therapies
Data Collection and Quality » Cellular Therapy » CIBMTR Guidance Document for Reporting Autologous Cellular Therapies
Please consider the following guidance when determining whether to report a cellular therapy to CIBMTR. The scope of this document covers autologous cellular therapies only. Reporting autologous cellular therapy data to CIBMTR Reporting of autologous cellular…
Q3: Hematopoietic Cellular Transplant (HCT)
FormsNet3 Process and Tool Instructions » 2814: Indication for CRID Assignment » Q3: Hematopoietic Cellular Transplant (HCT)
Questions 3: Is the product genetically modified? For multiple products, report “Yes” if ANY of the products are genetically modified. Genetically modified products include any product where the cells are manipulated via either: Gene transfer: A process…
Genetic Mutation Reporting
Data Collection and Quality » NMDP Forms » Genetic Mutation Reporting
NMDP has implemented a protocol consent change and is introducing a standardized way to report genetic mutations detected in donor-derived cells. Historically, the process to report findings has not been outlined and occurs on a case-by-case basis. By standardizing…
US Transplant Centers
Protocols and Consents » US Transplant Centers
United States Transplant Centers – Institutional Review Board (IRB) Approval: To be compliant with United States Federal Regulations for human research subject protection, transplant centers must obtain IRB-approved informed consent from recipients to allow data…
Center Participation
Center Participation
Center Status Level Assignment The Stem Cell Therapeutic Outcomes Database (SCTOD) is part of the C.W. Bill Young Cell Transplantation Program (Program), authorized by the Stem Cell Therapeutic and Research Act of 2005 (Public Law 109-129) and reauthorized by the Stem…
Adverse Event and Product Complaint Reporting
Data Collection and Quality » NMDP Forms » Adverse Event and Product Complaint Reporting
NMDP requires transplant centers to report all qualifying recipient adverse events and/or product complaint events on all recipients of cellular product that we facilitate. FormsNet3 is a system used by the Event Reporting System (ERS) to capture information about…
CPI Forms and Due Dates
Continuous Process Improvement Program (CPI) » Form Completion Standards » CPI Forms and Due Dates
!Adjusted Form Due Date: The form due date will automatically recalculate if the new form added is more than four months past its original form due date. The adjusted due date will be the date the form was created minus four months. The FormsNet3 Forms Grid will…
Completing Error Correction Forms
Data Collection and Quality » Correcting Historical Data » Completing Error Correction Forms
The banner box needs to be completed for each page. Provide the Sequence Number from the original form Provide the CRID, Infusion Date, and Center Number Today’s Date – is the date you are completing the EC Provide your initials in the…
Acronyms
Acronyms
AA: African American ABil: Acute biphenotypic leukemias AC: apheresis center ACCME: Accreditation Council for Continuing Medical Education AFA: Anti-fungal agent AGNIS: A Growable Network Information System ALL: Acute lymphoblastic leukemia, acute lymphocytic…
Section 1: Completed by transferring TO center
FormsNet3 Process and Tool Instructions » Recipient Transfer Tool » Section 1: Completed by transferring TO center
Section 1 of the recipient transfer tool is completed by the center where the recipient is transferring TO. !The TO center and FROM center should be in contact with one another prior to completing the Recipient Transfer to ensure that both centers are referring to the…
PHI
Public Health Authority and Protected Health Information » PHI
Protected Health Information (PHI) and the CIBMTR Research ID (CRID) In order to create a universal unique ID system, CIBMTR collects protected health information (PHI), including but not limited to identifiers such as name, social security number (SSN), mother’s…
Fee Schedule
Fee Schedule
Fee Schedule for Forms Completion CIBMTR pays transplant centers for all completed Comprehensive Report Forms and Cellular Therapy Forms. Reporting of TED level data is not compensated, with the exception of the Form 2006 when requested for recipients on the TED…
Frequently Asked Questions (FAQ)
Center Volume Data Reports (CVDR) » Resources » Frequently Asked Questions (FAQ)
How will CIBMTR inform my center the CVDR Portal is open and dataset ready for review? An eBlast announcement will be distributed to centers informing them of the dates the CIBMTR CVDR dataset/portal will be open and available for review. When should I review my…
Network Partner Portal
Access to CIBMTR Systems » Network Partner Portal
!This information is specific to the Primary Data Manager or Medical Director role. To get someone access to CIBMTR systems (FormsNet3, the CIBMTR Portal, and CIBMTR Center Support) the Primary Data Manager will need to add an account in the Network Partner…
Q1-10: Consent Information
FormsNet3 Process and Tool Instructions » FormsNet3 Consent Tool » Q1-10: Consent Information
Question 1: Consent status for submitting research data to CIBMTR !To be compliant with Federal Regulation for human research protection, centers must obtain IRB-approved informed consent from recipients and donors (if applicable, for the related donor sample…
Public Health Authority and Protected Health Information
Public Health Authority and Protected Health Information
Public Health Authority (PHA) Status CIBMTR meets the U.S. Department of Health & Human Services HIPAA Privacy Rule’s definition of a public health authority (PHA) and is authorized by law to collect the information necessary to fulfill the legislated mandate to…
Q1-13: Demographics
FormsNet3 Process and Tool Instructions » 2804: CIBMTR Research ID Assignment » Q1-13: Demographics
*This form must be completed for all individuals on whom data is submitted to CIBMTR. CIBMTR is a Public Health Authority (PHA) under the Health Insurance Portability and Accountability Act (HIPAA). In this capacity, CIBMTR is authorized to collect individually…
Q4-6: Non-Cellular Therapy
FormsNet3 Process and Tool Instructions » 2814: Indication for CRID Assignment » Q4-6: Non-Cellular Therapy
Question 4: Specify the disease / study for which non-cellular therapy was given Indicate if the individual is participating in the BMT CTN 17-02 study or receiving non-cellular therapy as treatment for MDS, multiple myeloma, myelofibrosis, sickle cell disease, or…
Overview & Timeline
Transplant Center Specific Analysis (TCSA) » Overview & Timeline
What is TCSA? Transplant Center Specific Analysis (TCSA), also referred to as Center Specific Analysis (CSA) or Center Outcomes Analysis, is used to predict one-year survival of first allogeneic transplants, based on data reported to CIBMTR. This program is mandatory…
Allo- NMDP Donor
Data Collection and Quality » How Forms Come Due » HCT » Forms 2003, 2004, 2005, 2006, 4003 » Allo- NMDP Donor
For each NMDP Donor instance, regardless of: HCT type (ALLO_U, ALLO_R) Product Type (PBSC, BM, CBU) Form Track (TED, CRF) F2400 ‘Was this donor used for any prior HCTs’ (Yes, No) a F2006 will come due. *On the Pre-TED (F2400), questions will…
2804: CIBMTR Research ID Assignment
FormsNet3 Process and Tool Instructions » 2804: CIBMTR Research ID Assignment
The CIBMTR Research ID (CRID) is a unique identifier assigned when an individual is registered with CIBMTR as receiving a cellular therapy, including hematopoietic stem cell transplant (HCT), cellular therapy (CT), treatment for marrow toxic injuries, or certain…
Data Collection and Quality
Data Collection and Quality
CIBMTR, in collaboration with the worldwide hematopoietic cell transplantation community, developed appropriately organized forms to capture a standard set of data elements for all transplant recipients. These forms are revised as needed to match the evolving science…
Research Sample Repository
Protocols and Consents » Research Sample Repository
The Research Sample Repository contains blood samples from unrelated recipients and/or their adult volunteer donor, or cord blood unit. Related allogeneic recipients and/or donors will participate at selected transplant centers. The primary objective of the Research…
Determining Reporting Levels: US Centers
Center Participation » Determining Reporting Levels: US Centers
For US centers, the Center Participation Status with NMDP and CIBMTR programs will determine the allowable reporting levels and the subsequent data collection forms the transplant center will be required to submit to the CIBMTR. This designation will inform the CPI…
Determining Reporting Levels: International Centers
Center Participation » Determining Reporting Levels: International Centers
For international centers, the Center Participation Status with NMDP and CIBMTR programs will determine the allowable reporting levels and the subsequent data collection forms the transplant center will be required to submit to the CIBMTR. This designation will inform…
CPI Center Forms Due Tool
Continuous Process Improvement Program (CPI) » CPI Resources » CPI Center Forms Due Tool
A real-time report can be run to generate a list of CPI forms due any time using the Center Forms Due tool. Under Recipient tab, select Center Forms Due from the Menu bar. For generalized instructions on creating a Forms Due list, please visit Recipient Center Forms…
Cell Therapy Corporate Studies
Corporate Studies and Registries » Cell Therapy Corporate Studies
*Questions regarding any of the below studies should be submitted via CIBMTR Center Support Current CIBMTR Cell Therapy Studies Enrollment into these cellular studies is done when the product name is reported on the F4000. No additional consent is required.…
Q19-22: Outcomes Registry Reporting
FormsNet3 Process and Tool Instructions » 2804: CIBMTR Research ID Assignment » Q19-22: Outcomes Registry Reporting
Indicate and provide identifiers for all other outcomes registries the individual’s data are being reported to. If the individual’s data are not being reported to any other outcomes registries, continue with the signature section of the form. If the individual’s…
Q1-5: Indication
FormsNet3 Process and Tool Instructions » 2820: Recipient Contact Information » Q1-5: Indication
Question 1: Did this Form 2820 become due because the recipient agreed to direct contact by CIBMTR for research studies as indicated on Form 2400? This question should be answered ‘yes’ if the recipient has given permission to be directly contacted by CIBMTR for…
Common Cell Therapy Related Questions
Data Collection and Quality » Cellular Therapy » Common Cell Therapy Related Questions
The recipient had a CAR-T infusion followed by an HCT. I see cell therapy forms with the HCT event date, is this correct? What you are seeing is “combined follow-up”. The intent of “combined follow-up” (when a recipient receives both an HCT and…
Q1-2: Indication
FormsNet3 Process and Tool Instructions » 2814: Indication for CRID Assignment » Q1-2: Indication
*Gene Therapy: If the infusion type is a gene therapy, the recipient will be placed on the HCT CRF track. Question 1: What is the indication for CIBMTR Research ID (CRID) assignment? Indicate whether the individual will be receiving hematopoietic cellular transplant…
Inclusion Criteria
Transplant Center Specific Analysis (TCSA) » Inclusion Criteria
TCSA Inclusion Criteria Inclusion criteria for this dataset are based on center activity and patient characteristics. For a transplant to be included, it must be a patient’s first allogeneic transplant, it must have been given at a U.S. or select international…
2820: Recipient Contact Information
FormsNet3 Process and Tool Instructions » 2820: Recipient Contact Information
The Recipient Contact Information Form 2820 collects contact information on recipients who have agreed to be contacted directly by CIBMTR for the purpose of inviting them to participate in research activities. If the recipient is a minor, contact information for the…
FormsNet3
Data Collection and Quality » FormsNet3
More than 95% of data collected by the CIBMTR is submitted electronically via FormsNet3, a comprehensive electronic data capture system containing greater than 250 forms related to the capturing of HCT outcomes for donors and recipients. The FormsNet3 application is…
Dataset
Center Volume Data Reports (CVDR) » Dataset
The CVDR report includes transplants from the past five years performed by domestic transplant centers. The variables in these reports include identifiers (CCN, center name, center city, center state, CRID, event date, and event year), recipient demographics…
Q22–38: Parent / Legal Guardian Contact Information
FormsNet3 Process and Tool Instructions » 2820: Recipient Contact Information » Q22–38: Parent / Legal Guardian Contact Information
Question 22 – 23: First Name, Last Name Report the complete legal first name of the recipient’s parent / legal guardian in question 22 and complete legal last name in question 23. Question 24: Indicate language preference Select the parent / legal…
Combined-Follow Up Scenarios (HCT + CT (Genetically Modified))
Data Collection and Quality » Cellular Therapy » How Forms Come Due » Combined-Follow Up Scenarios (HCT + CT (Genetically Modified))
As of the Summer 2020 Release, CIBMTR implemented a hard stop when reporting multiple genetically modified cellular therapies and HCTs that require follow-up forms. This new functionality has been implemented to reduce center reporting burden and redundancies when…
Autologous
Data Collection and Quality » How Forms Come Due » HCT » Forms 2003, 2004, 2005, 2006, 4003 » Autologous
For each Autologous instance, Form 2003 (Gene Therapy) Form 2004 Form 2005 Form 2006 or 4003 TED or CRF track Genetically modified = yes X X (F4003 only) TED or CRF track Product Type = Cord Blood…
Monthly Maintenance Items for FormsNet3
Data Collection and Quality » Monthly Maintenance Items for FormsNet3
Each month the FormsNet3 team makes updates to validations, question enabling/disabling and form generation. The monthly maintenance updates are tentatively scheduled for the 4th Friday of the month. March 2024 (released March 22nd, 2024) Form_Revision…
Observational Database
Protocols and Consents » Observational Database
When a recipient consents to participate in research, their data are contained in the CIBMTR’s Observational Database. The database includes recipient baseline and outcome data for related and unrelated allogeneic transplants or other cellular therapy from any cell…
Cell Therapy Training Resources
Data Collection and Quality » Cellular Therapy » Cell Therapy Training Resources
CIBMTR Portal Click HERE to access the Portal (https://portal.cibmtr.org/) Click on the “Training & eLearnings” tile Resources Available on the CIBMTR Portal Self-Guided New Data Manager Onboarding: The Center for International Blood & Marrow…
User Updates
Access to CIBMTR Systems » Network Partner Portal » User Updates
Creating a New User From the Select Your Center field, choose the center from the dropdown the new user will be associated with. In the Select New User’s Role field, select the appropriate job role for your new user. Next to each role is a short description of…
Legacy Error Corrections
Data Collection and Quality » Correcting Historical Data » Legacy Error Corrections
How to make changes to Legacy Data “Legacy data” are data submitted to CIBMTR or NMDP before the FormsNet2 application became available on December 3, 2007. If you need to make changes to data that were submitted to the legacy databases, please send an error…
Cell Therapy Reporting Preferences
Data Collection and Quality » Cellular Therapy » Cell Therapy Reporting Preferences
Cell therapy reporting preferences took effect in July 2022 and are used to determine how forms come due. *Donor Lymphocyte Infusions (DLIs) are not included as a type of cellular therapy for the purpose of reporting preference. As of September 2022, DLIs are no…
Protocols and Consents
Protocols and Consents
Transplant centers are expected to approach all recipients for consent to participate in the Clinical Outcomes Research Database. Centers participating in the Research Sample Repository should approach all unrelated recipients, as well as all related donor/recipient…
Q6–21: Recipient Contact Information
FormsNet3 Process and Tool Instructions » 2820: Recipient Contact Information » Q6–21: Recipient Contact Information
Question 6 – 7: First Name, Last Name Report the recipient’s complete legal first name in question 1 and complete legal last name in question 2. Question 8: Indicate language preference: Select the recipient’s primary language preference. If the…
Multiple Myeloma/Plasma Cell Disorder (PCD)
Data Collection and Quality » Primary Disease and Disease Forms Due » Multiple Myeloma/Plasma Cell Disorder (PCD)
Disease Subtype(s) HCT Disease Inserts required Cellular Therapy Disease Inserts required Multiple myeloma (178) Multiple myeloma-light chain only (186) Multiple myeloma non-secretory (187) Plasma cell leukemia (172) Solitary plasmacytoma…
Posting
Transplant Center Specific Analysis (TCSA) » Posting
Public Posting: HRSA Transplant Outcomes The data posted by Health Resources and Service Administration (HRSA), known as Transplant Outcomes, includes reports of patient outcomes and other information about transplants. Transplants in these reports were performed at…
Forms Due List
Corporate Studies and Registries » Forms Due List
CIBMTR Corporate Studies and Registries Forms Due List The Corporate Studies and Registries Forms Due List is automatically sent each Tuesday via email. If you have questions about forms in these reports, contact CIBMTR Center Support. Your center will receive this…
Q39–58: Alternate Contact Information
FormsNet3 Process and Tool Instructions » 2820: Recipient Contact Information » Q39–58: Alternate Contact Information
This section will enable when a specific study requires an alternate contact, such as a caregiver, who is not the recipient’s parent / guardian. This section is currently disabled as it is not required for the following studies: BMT CTN 1702, BMT CTN 1703, or BMT CTN…
Survival Form Status
Data Collection and Quality » FormsNet3 » Survival Form Status
When you have a patient that is further out from transplant, you know is alive and all efforts to obtain follow-up data on a patient have failed, you can report the recipient’s latest alive date of contact, thus eliminating the need to override multiple questions…
Non-Hodgkin Lymphoma
Data Collection and Quality » Primary Disease and Disease Forms Due » Non-Hodgkin Lymphoma
Disease Subtype(s) HCT Disease Inserts required Cellular Therapy Disease Inserts required B-cell neoplasms ALK+ large B-cell lymphoma (1833) B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin…
Allo_Unrelated Donor (Non-NMDP)
Data Collection and Quality » How Forms Come Due » HCT » Forms 2003, 2004, 2005, 2006, 4003 » Allo_Unrelated Donor (Non-NMDP)
For each Non-NMDP Unrelated instance, Form 2004 Form 2005 Form 2006 or 4003 CRF track Was the donor used for a prior HCT = yes X X (For each product) CRF track Was the donor used for a prior HCT = no X…
Allo_Related Donor (Non-NMDP)
Data Collection and Quality » How Forms Come Due » HCT » Forms 2003, 2004, 2005, 2006, 4003 » Allo_Related Donor (Non-NMDP)
For each Related Donor instance, where F2400 ‘Was this donor used for any prior HCTs’ = No Related Donor type: Syngeneic (monozygotic twin) or HLA-Identical Sibling Form 2004 Form 2005 Form 2006 or 4003 CRF track X …
FormsNet3
Access to CIBMTR Systems » FormsNet3
Obtaining Access For a FormsNet3 user, once the account is created, the person must also be assigned an application user role in FormsNet3. Without a role, the user will not be associated with a center and will be unable to access the Recipient tab in the FormsNet3…
Cell Therapy Reporting Tracks and Follow-Up Schedules
Data Collection and Quality » Cellular Therapy » Cell Therapy Reporting Tracks and Follow-Up Schedules
Beginning in July of 2023, a reporting track will now be set for all cell therapy CRIDs reported to CIBMTR. The track will be set by the center reporting preference and infusion type. *TED vs CRF reporting for cellular therapy was launched in the Summer 2023 release.…
Recipient Transfer Tool
FormsNet3 Process and Tool Instructions » Recipient Transfer Tool
The Request for Recipient Transfer, is used when a recipient has left one center and transferred to a different center for treatment after having been reported at the previous center. The Request for Recipient Transfer is completed in FormsNet3 by the data managers at…
Correcting Historical Data
Data Collection and Quality » Correcting Historical Data
With the release of FormsNet3, all corrections to Legacy Data (submitted prior to FormsNet2) and FormsNet2 forms that aren’t FormsNet3 editable, need to be sent via Paper Error Corrections. Data entered into FormsNet3 (since 12/4/12) or on FormsNet3 editable…
Q14-18: Recipient Identifiers
FormsNet3 Process and Tool Instructions » 2804: CIBMTR Research ID Assignment » Q14-18: Recipient Identifiers
Complete all additional individual identifiers, as applicable. Question 14: Recipient NMDP ID Report the seven-digit recipient ID (RID) assigned by NMDP. If the individual has never been assigned an NMDP RID, leave this data field blank. For RELATED donors, do not…
Overview & Timeline
Center Volume Data Reports (CVDR) » Overview & Timeline
Overview Annually, as part of our contract with the U.S. Health Resources and Services Administration (HRSA), CIBMTR publishes transplant center volumes data on the C.W. Bill Young Cell Transplantation Program government website. The hematopoietic cell transplantation…
Generating a CPI Center Forms Due Report
Continuous Process Improvement Program (CPI) » CPI Resources » CPI Center Forms Due Tool » Generating a CPI Center Forms Due Report
Step 1: Status codes – Click on the Step 2: Forms – Click on the Step 3: Click on US CPI or Non-US CPI (should auto-populate) Step 4: The Date Type will auto-populate to Form Due Date. Critical Forms Due On Time Forms Due during…